A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma

BACKGROUND: Oxaliplatin is a platinum derivative that has shown efficacy in advanced hepatocellular carcinoma. S-1 is an oral fluoropyrimidine that has substituted for 5-fluorouracil in many cancers. This was a multicenter, open-label, single-arm phase II trial that evaluated the efficacy of S-1 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dae-Won, Lee, Kyung-Hun, Kim, Hee-Jun, Kim, Tae-Yong, Kim, Jin-Soo, Han, Sae-Won, Oh, Do-Youn, Kim, Jee Hyun, Im, Seock-Ah, Kim, Tae-You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838934/
https://www.ncbi.nlm.nih.gov/pubmed/29506478
http://dx.doi.org/10.1186/s12885-018-4039-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838934/
https://www.ncbi.nlm.nih.gov/pubmed/29506478
http://dx.doi.org/10.1186/s12885-018-4039-9

Ejemplares similares